Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors. (NCT06928363) | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 2025-05-01 |
| A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome (NCT06518876) | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 2024-08-31 |
| A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma (NCT06223646) | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 2024-01-11 |
| Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT06175780) | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 2022-12-28 |
Track Novatim Immune Therapeutics (Zhejiang) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.